Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Post by Liked2Thinkon Jun 17, 2021 1:14pm
154 Views
Post# 33404959

Last Operational Updates & Recent Highlights

Last Operational Updates & Recent HighlightsFrom their last finacial report on May 17 they had the following listing as highlights of Q1
1. Aristotle launched
2. LOI to acquire the clinics
3. More testing 100% due to Ichor in Canada
4. Hired further staff and expanding testing capacity for covid-19 and Aristotle
5. Parntership with Rexall to sell covid 19 saliva test kits
6. Partnerships with additional Fortune 500 companies for covid 19 testing.

My opinions on each
1. Yes launched but to what extent?  We dont know and wont have numbers on tests ever.
2. hopefully the clinics are all wrapped up by July 17th but they had said it wouldnt be until Q3.  Hopefully that is included and taken care of when they release their Q2 results as technically we will be in Q3 then but lets face it, it could be done in sept and still be classified as Q3.  Im thinking it will be July 17 all wrapped up though.
3. Ichor still kicking a$$ like they do.  This wont change
4. Why are they hiring more staff?  They have a 1,000 covid tests per day capacity but looking at the numbers of previous quarters they have peaked at maybe 500 tests per day.  Thats 5 days a week only day shift.  They have not added a night shift or weekend shifts.  At least thats how I calculate it.  I figure the 1,000 tests per day capacity is if they do a day and night shift because then technically they can do 1,000 tests per day.  Demand is obviously not there to do more than 500 max which boggles the mind as covid is the worst thing EVER apparently.  If I am wrong in my math then why do they need more people?  if they can do 1,000 covid tests a day but are only doing 500 cant the people they have that would complete the other 500 just work on the Aristotle testing instead?
5. rexall partnershiip is good.  unknown just how popular it is as I think the dollar amount is high for some people and I dont think traveling has really gotten as busy as it will be.  Doubt much of anything with this program will occur until Q3 results.  One possibility is if Ichor can do their stuff and get in more with them and get in with someone in Canada to start with Aristotle testing thats a big hope of mine with Ichor.
6. "Additional partnerships" with Fortune 500 companies.  What have we got with are so called previous parnterships?  Nothing that I can tell.



<< Previous
Bullboard Posts
Next >>